Clinical use of cobicistat as a pharmacoenhancer of human immunodeficiency virus therapy
Clinical use of cobicistat as a pharmacoenhancer of human immunodeficiency virus therapy
About this item
Full title
Author / Creator
Publisher
New Zealand: Taylor & Francis Ltd
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Taylor & Francis Ltd
Subjects
More information
Scope and Contents
Contents
The pharmacoenhancement of plasma concentrations of protease inhibitors by coadministration of so-called boosters has been an integral part of antiretroviral therapy for human immunodeficiency virus (HIV) for 1.5 decades. Nearly all HIV protease inhibitors are combined with low-dose ritonavir or cobicistat, which are able to effectively inhibit the...
Alternative Titles
Full title
Clinical use of cobicistat as a pharmacoenhancer of human immunodeficiency virus therapy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_954ef647f6c445ce81d4960adf07588a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_954ef647f6c445ce81d4960adf07588a
Other Identifiers
ISSN
1179-1373
E-ISSN
1179-1373
DOI
10.2147/HIV.S70836
